2nd Quarter - Report
TIBER CREEK HEALTH STRATEGIES, INC. for GENENTECH, INC.
Client
Income
$50,000
Expenses
—
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Pharmacy PHA
Proposed cuts to Part B reimbursement. 340b reimbursement policy. S. 3187, the Food and Drug Administration Safety and Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRYANT HALL | — |
Health Issues HCR
Proposed cuts to Part B reimbursement. 340b reimbursement policy. S. 3187, the Food and Drug Administration Safety and Innovation Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRYANT HALL | — |
Medicare/Medicaid MMM
Proposed cuts to Part B reimbursement.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JAMES BRYANT HALL | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.